Clinical chemistry-specific protein IVDs Australia - engelsk - Department of Health (Therapeutic Goods Administration)

clinical chemistry-specific protein ivds

innovation scientific pty ltd - ct974 - clinical chemistry-specific protein ivds - ivds that are intended to be used for the qualitative and/or quantitative determination of proteins specific to clinical chemistry, in a clinical specimen for professional use only.

Ostelin Specialist Range Vitamin D 7000IU Australia - engelsk - Department of Health (Therapeutic Goods Administration)

ostelin specialist range vitamin d 7000iu

sanofi-aventis healthcare pty ltd t/a sanofi consumer healthcare - colecalciferol, quantity: 175 microgram - capsule, soft - excipient ingredients: soya oil; purified water; patent blue v; gelatin; glycerol; dl-alpha-tocopherol; allura red ac; titanium dioxide; propylene glycol; ethyl acetate; ethanol; isopropyl alcohol; strong ammonia solution; polyvinyl acetate phthalate; macrogol 400 - for the treatment of vitamin d deficiency in adults and adolescents as directed by your medical practitioner or pharmacist.,for the prevention of vitamin d deficiency in high risk individuals under the supervision of a medical practitioner.

Clinical chemistry-specific protein IVDs Australia - engelsk - Department of Health (Therapeutic Goods Administration)

clinical chemistry-specific protein ivds

zimmer biomet pty ltd - ct974 - clinical chemistry-specific protein ivds - a qualitative ivd intended as an adjunct for the detection of joint infection in synovial fluid of patients experiencing pain/inflammation in a replacement joint. intended to provide positive/negative result for the presence of alpha-defensin in synovial fluid. not intended to identify a specific type of infection, establish origin or severity of infection. for clinical use by healthcare professionals; not for point-of-care/near-patient use, self-use, self-test, or home use.

Clinical chemistry-specific protein IVDs Australia - engelsk - Department of Health (Therapeutic Goods Administration)

clinical chemistry-specific protein ivds

abacus dx pty ltd - ct974 - clinical chemistry-specific protein ivds - ivds that are intended to be used for the qualitative and/or quantitative determination of specific proteins in a clinical specimen.

SEPTANEST 1:200,000 articaine HCl 4% with adrenaline 1:200,000, solution for injection 2.2 mL cartridge Australia - engelsk - Department of Health (Therapeutic Goods Administration)

septanest 1:200,000 articaine hcl 4% with adrenaline 1:200,000, solution for injection 2.2 ml cartridge

specialites septodont pty ltd - articaine hydrochloride, quantity: 88 mg; adrenaline (epinephrine) acid tartrate, quantity: 0.02 mg (equivalent: adrenaline (epinephrine), qty 0.011 mg) - injection, solution - excipient ingredients: sodium chloride; sodium metabisulfite; sodium hydroxide; water for injections - ? septanest 1:200,000 is indicated for local anaesthesia for simple dental procedures in adults, adolescents and children 4 years of age and older. ? septanest 1:200,000 is indicated only for dental procedures

Clinical chemistry-specific protein IVDs Australia - engelsk - Department of Health (Therapeutic Goods Administration)

clinical chemistry-specific protein ivds

abacus dx pty ltd - ct974 - clinical chemistry-specific protein ivds - ivds intended to be used for the qualitative and/or quantitative determination of proteins specific to clinical chemistry, in a clinical specimen.

Captia Malaria EIA - Multiple Plasmodium species total antibody IVD, kit, enzyme immunoassay (EIA) Australia - engelsk - Department of Health (Therapeutic Goods Administration)

captia malaria eia - multiple plasmodium species total antibody ivd, kit, enzyme immunoassay (eia)

abbott rapid diagnostics pty ltd - 52327 - multiple plasmodium species total antibody ivd, kit, enzyme immunoassay (eia) - captia malaria eia uses four recombinant antigens in a sandwich test to produce a test that is both specific and sensitive. the antigens will detect p falciparum and p. vivax -specific igg, igm, and iga, enabling the test to detect antibodies during all stages of infection. the assay can be used with both serum and plasma. this kit is intended for use by appropriately trained and qualified personnel for the qualitative and semi-quantitative detection of antibodies to plasmodium falciparum (p. falciparum) and plasmodium vivax (p. vivax), in human serum and plasma.

Clinical chemistry - Clinical chemistry-specific protein IVDs Australia - engelsk - Department of Health (Therapeutic Goods Administration)

clinical chemistry - clinical chemistry-specific protein ivds

qiagen pty ltd - ct974 - clinical chemistry-specific protein ivds - tests to be used for the qualitative and/or quantitative detection of proteins specific to clinical chemistry in a clinical specimen.

SEPTANEST 1:200,000 articaine HCl 4% with adrenaline 1:200,000, solution for injection 1.7 ml cartridge Australia - engelsk - Department of Health (Therapeutic Goods Administration)

septanest 1:200,000 articaine hcl 4% with adrenaline 1:200,000, solution for injection 1.7 ml cartridge

specialites septodont pty ltd - articaine hydrochloride, quantity: 68 mg; adrenaline (epinephrine) acid tartrate, quantity: 0.0155 mg (equivalent: adrenaline (epinephrine), qty 0.0085 mg) - injection, solution - excipient ingredients: sodium chloride; sodium metabisulfite; sodium hydroxide; water for injections - ? septanest 1:200,000 is indicated for local anaesthesia for simple dental procedures in adults, adolescents and children 4 years of age and older. ? septanest 1:200,000 is indicated only for dental procedures

Clinical chemistry-specific protein IVDs Australia - engelsk - Department of Health (Therapeutic Goods Administration)

clinical chemistry-specific protein ivds

beckman coulter australia pty ltd - ct974 - clinical chemistry-specific protein ivds - ivds that are intended to be used for the qualitative and/or quantitative determination of proteins specific to clinical chemistry, in a clinical specimen